Aardvark Therapeutics Statistics
NASDAQ: AARDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.96-0.08 (-1.59%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Aardvark Therapeutics by the numbers
Aardvark Therapeutics has a market capitalization of $108.5 million based on 21.88M shares outstanding. With trailing EPS of $-3.21, Aardvark Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 17.8% below its 50-day average and 31.9% below its 200-day average.
Average daily trading volume is 210.14K shares, or about $1.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AARD valuation vs. peer median
| Metric | AARD | Peer median | Difference |
|---|---|---|---|
| Market cap | $108.55M | $113.64M | -4% |
| Avg. volume | 210.14K | 460.29K | -54% |
Peer median across 8 companies: PMVP, GNLX, RANI, CRBP, KZIA, UNCY, COYA, PLYX.
Valuation
- Market cap
- $108.55M
- EPS (TTM)
- $-3.21
- Shares outstanding
- 21.88M
Price and trading
- Previous close
- 5.04
- Open
- 4.95
- Day range
- 4.70 – 5.33
- 52-week range
- 3.35 – 17.94
- 52-week change
- -71.51%
- Beta
- —
- Volume
- 212.04K
- Average volume
- 210.14K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 108.55M
- Forward Pe
- -2.08
- Eps
- -3.21
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 17.94
- Week52 Low
- 3.35
- Avg Volume
- 210.14K
- Shares Outstanding
- 21.88M
- Ma50
- 6.03
- Ma200
- 7.28
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -72.35%
- Pct From52w Low
- 48.06%